Gemcitabine Hydrochloride With or Without GDC-0449 in Treating Patients With Recurrent or Metastatic Pancreatic Cancer
 
Sponsors and Collaborators

University of Chicago
National Cancer Institute (NCI)
 
Contact
Clinical Trials Office – University of Chicago Cancer Research
773-834-7424
 
Principal Investigators
Hedy L. Kindler, MD
University of Chicago
 
ClinicalTrials.gov Identifier
NCT01064622